Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Issue 10293 (26th June 2021)
- Record Type:
- Journal Article
- Title:
- Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Issue 10293 (26th June 2021)
- Main Title:
- Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
- Authors:
- Azizi, Michel
Sanghvi, Kintur
Saxena, Manish
Gosse, Philippe
Reilly, John P
Levy, Terry
Rump, Lars C
Persu, Alexandre
Basile, Jan
Bloch, Michael J
Daemen, Joost
Lobo, Melvin D
Mahfoud, Felix
Schmieder, Roland E
Sharp, Andrew S P
Weber, Michael A
Sapoval, Marc
Fong, Pete
Pathak, Atul
Lantelme, Pierre
Hsi, David
Bangalore, Sripal
Witkowski, Adam
Weil, Joachim
Kably, Benjamin
Barman, Neil C
Reeve-Stoffer, Helen
Coleman, Leslie
McClure, Candace K
Kirtane, Ajay J
Sanghvi, Kintur
Costello, Josh
Krathan, Courtney
Lewis, Luot
McElvarr, Andrew
Reilly, John
Jenkins, Stephen
Cash, Michael
Williams, Shannon
Jarvis, Maria
Fong, Pete
Laffer, Cheryl
Gainer, James
Robbins, Mark
Crook, Sherron
Maddel, Sarita
Hsi, David
Martin, Scott
Portnay, Edward
Ducey, Maryanne
Rose, Suzanne
DelMastro, Elizabeth
Bangalore, Sripal
Williams, Stephen
Cabos, Stanley
Rodriguez Alvarez, Carolina
Todoran, Thomas
Basile, Jan
Powers, Eric
Hodskins, Emily
Paladugu, Vijay
Tecklenburg, Anna
Devireddy, Chandan
Lea, Janice
Wells, Bryan
Fiebach, Amanda
Merlin, Claudia
Rader, Florian
Dohad, Suhail
Kim, Hyun-Min
Rashid, Mohammad
Abraham, Josephine
Owan, Theophilus
Abraham, Anu
Lavasani, Iran
Neilson, Hailey
Calhoun, David
McElderry, Thomas
Maddox, William
Oparil, Suzanne
Kinder, Sheila
Kirtane, Ajay J
Radhakrishnan, Jai
Batres, Candido
Edwards, Suzanne
Garasic, Joseph
Drachman, Doug
Zusman, Randy
Rosenfield, Kenneth
Do, Danny
Khuddus, Matheen
Zentko, Suzanne
O'Meara, James
Barb, Ilie
Foster, Abby
Boyette, Alice
Wang, Yale
Jay, Desmond
Skeik, Nedaa
Schwartz, Robert
Peterson, Rose
Goldman, Jo Anne
Goldman, Jessie
Ledley, Gary
Katof, Nancy
Potluri, Srinivasa
Biedermann, Scott
Ward, Jacquelyn
White, Megan
Fisher, Naomi DL
Mauri, Laura
Sobieszczky, Piotr
Smith, Alex
Aseltine, Laura
Stouffer, Rick
Hinderliter, Alan
Pauley, Eric
Wade, Tyrone
Zidar, David
Shishehbor, Mehdi
Effron, Barry
Costa, Marco
Semenec, Terence
Bloch, Michael J
Roongsritong, Chanwit
Nelson, Priscilla
Neumann, Bridget
Cohen, Debbie
Giri, Jay
Neubauer, Robin
Vo, Thu
Chugh, Atul R
Huang, Pei-Hsiu
Jose, Powell
Flack, John
Fishman, Robert
Jones, Michael
Adams, Todd
Bajzer, Christopher
Saxena, Manish
Lobo, Melvin D
Mathur, Anthony
Jain, Ajay
Balawon, Armida
Zongo, Olivier
Levy, Terry
Bent, Clare
Beckett, David
Lakeman, Nicki
Kennard, Sarah
Sharp, Andrew
D'Souza, Richard J
Statton, Sarah
Wilkes, Lindsay
Anning, Christine
Sayer, Jeremy
Iyer, Sudha Ganesh
Robinson, Nicholas
Sevillano, Annaliza
Ocampo, Madelaine
Gerber, Robert
Faris, Mohamad
Marshall, Andrew John
Sinclair, Janet
Pepper, Hayley
Davies, Justin
Chapman, Neil
Burak, Paula
Carvelli, Paula
Jadhav, Sachin
Quinn, Jane
Rump, Lars Christian
Stegbauer, Johannes
Schimmöller, Lars
Potthoff, Sebastian
Schmid, Claudia
Roeder, Sylvia
Weil, Joachim
Hafer, Lukas
Agdirlioglu, Tolga
Köllner, Tanja
Mahfoud, Felix
Böhm, Michael
Ewen, Sebastian
Kulenthiran, Saarraaken
Wachter, Angelika
Koch, Christina
Lurz, Philipp
Fengler, Karl
Rommel, Karl-Philipp
Trautmann, Kai
Petzold, Martin
Schmieder, Roland E
Ott, Christian
Schmid, Axel
Uder, Michael
Heinritz, Ulrike
Fröhlich-Endres, Kerstin
Genth-Zotz, Sabine
Kämpfner, Denise
Grawe, Armin
Höhne, Johannes
Kaesberger, Bärbel
von zur Mühlen, Constantin
Wolf, Dennis
Welzel, Markus
Heinrichs, Gudrun
Trabitzsch, Barbara
Gosse, Philippe
Cremer, Antoine
Trillaud, Hervé
Papadopoulos, Panteleimon
Maire, Florent
Gaudissard, Julie
Azizi, Michel
Sapoval, Marc
Cornu, Erika
Fouassier, David
Livrozet, Marine
Lorthioir, Aurélien
Paquet, Valérie
Pathak, Atul
Honton, Benjamin
Cottin, Marianne
Petit, Frédéric
Lantelme, Pierre
Berge, Constance
Courand, Pierre-Yves
Langevin, Fatou
Delsart, Pascal
Longere, Benjamin
Ledieu, Guillaume
Pontana, François
Sommeville, Coralie
Bertrand, Fabien
Daemen, Joost
Feyz, Lida
Zeijen, Victor
Ruiter, Arno
Huysken, Elisabeth
Blankestijn, Peter
Voskuil, Michiel
Rittersma, Zwaantina
Dolmans, Helma
Kroon, A A
van Zwam, W H
Vranken, Jeannique
de Haan, Claudia
Persu, Alexandre
Renkin, Jean
Maes, Frédéric
Beauloye, Christophe
Lengelé, Jean-Philippe
Huyberechts, Dominique
Bouvie, Anne
Witkowski, Adam
Januszewicz, Andrzej
Kdziela, Jacek
Prejbisj, Aleksander
Hering, Dagmara
Ciecwierz, Dariusz
Jaguszewski, Milosz J
Owczuk, Radoslaw
Ciecwierz, Dariusz
Jaguszewski, Milosz J
… (more) - Abstract:
- Summary: Background: Endovascular renal denervation reduces blood pressure in patients with mild-to-moderate hypertension, but its efficacy in patients with true resistant hypertension has not been shown. We aimed to assess the efficacy and safety of endovascular ultrasound renal denervation in patients with hypertension resistant to three or more antihypertensive medications. Methods: In a randomised, international, multicentre, single-blind, sham-controlled trial done at 28 tertiary centres in the USA and 25 in Europe, we included patients aged 18–75 years with office blood pressure of at least 140/90 mm Hg despite three or more antihypertensive medications including a diuretic. Eligible patients were switched to a once daily, fixed-dose, single-pill combination of a calcium channel blocker, an angiotensin receptor blocker, and a thiazide diuretic. After 4 weeks of standardised therapy, patients with daytime ambulatory blood pressure of at least 135/85 mm Hg were randomly assigned (1:1) by computer (stratified by centres) to ultrasound renal denervation or a sham procedure. Patients and outcome assessors were masked to randomisation. Addition of antihypertensive medications was allowed if specified blood pressure thresholds were exceeded. The primary endpoint was the change in daytime ambulatory systolic blood pressure at 2 months in the intention-to-treat population. Safety was also assessed in the intention-to-treat population. This study is registered withSummary: Background: Endovascular renal denervation reduces blood pressure in patients with mild-to-moderate hypertension, but its efficacy in patients with true resistant hypertension has not been shown. We aimed to assess the efficacy and safety of endovascular ultrasound renal denervation in patients with hypertension resistant to three or more antihypertensive medications. Methods: In a randomised, international, multicentre, single-blind, sham-controlled trial done at 28 tertiary centres in the USA and 25 in Europe, we included patients aged 18–75 years with office blood pressure of at least 140/90 mm Hg despite three or more antihypertensive medications including a diuretic. Eligible patients were switched to a once daily, fixed-dose, single-pill combination of a calcium channel blocker, an angiotensin receptor blocker, and a thiazide diuretic. After 4 weeks of standardised therapy, patients with daytime ambulatory blood pressure of at least 135/85 mm Hg were randomly assigned (1:1) by computer (stratified by centres) to ultrasound renal denervation or a sham procedure. Patients and outcome assessors were masked to randomisation. Addition of antihypertensive medications was allowed if specified blood pressure thresholds were exceeded. The primary endpoint was the change in daytime ambulatory systolic blood pressure at 2 months in the intention-to-treat population. Safety was also assessed in the intention-to-treat population. This study is registered with ClinicalTrials.gov, NCT02649426 . Findings: Between March 11, 2016, and March 13, 2020, 989 participants were enrolled and 136 were randomly assigned to renal denervation (n=69) or a sham procedure (n=67). Full adherence to the combination medications at 2 months among patients with urine samples was similar in both groups (42 [82%] of 51 in the renal denervation group vs 47 [82%] of 57 in the sham procedure group; p=0·99). Renal denervation reduced daytime ambulatory systolic blood pressure more than the sham procedure (−8·0 mm Hg [IQR –16·4 to 0·0] vs –3·0 mm Hg [–10·3 to 1·8]; median between-group difference –4·5 mm Hg [95% CI –8·5 to –0·3]; adjusted p=0·022); the median between-group difference was –5·8 mm Hg (95% CI –9·7 to –1·6; adjusted p=0·0051) among patients with complete ambulatory blood pressure data. There were no differences in safety outcomes between the two groups. Interpretation: Compared with a sham procedure, ultrasound renal denervation reduced blood pressure at 2 months in patients with hypertension resistant to a standardised triple combination pill. If the blood pressure lowering effect and safety of renal denervation are maintained in the long term, renal denervation might be an alternative to the addition of further antihypertensive medications in patients with resistant hypertension. Funding: ReCor Medical. … (more)
- Is Part Of:
- Lancet. Volume 397:Issue 10293(2021)
- Journal:
- Lancet
- Issue:
- Volume 397:Issue 10293(2021)
- Issue Display:
- Volume 397, Issue 10293 (2021)
- Year:
- 2021
- Volume:
- 397
- Issue:
- 10293
- Issue Sort Value:
- 2021-0397-10293-0000
- Page Start:
- 2476
- Page End:
- 2486
- Publication Date:
- 2021-06-26
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5 - Journal URLs:
- http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0140-6736(21)00788-1 ↗
- Languages:
- English
- ISSNs:
- 0140-6736
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17329.xml